GlucoTrack (GCTK) Stock Analysis: AI Score & Alternative Data
GlucoTrack — alt-data steady across 90 days
Is GlucoTrack a buy right now? The alternative data says hold. This GCTK stock analysis is built on the 25+ alternative data signals AltIndex tracks on GlucoTrack every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 49/100: a Hold. The stock trades at $0.37 with a $5M market cap.
No core signal has moved more than 5% in 90 days — steady, but without the momentum that pushes a stock into buy territory.
GCTK’s broader alt-data profile also covers headcount (1 employees, according to LinkedIn), web traffic (7K monthly visits), Reddit mentions (1 a day), and sentiment (93/100). Every signal links to its own page with full history, the GCTK technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on GCTK is just below.
GlucoTrack AI Stock Analysis
GlucoTrack is a medical device company that specializes in offering non-invasive blood glucose monitoring solutions. The company aims to address the severe burden of regular blood glucose testing experienced by diabetic patients.
Analysis generated July 28, 2026.
Recent GlucoTrack Stock Alerts
![]() |
GlucoTrack | August 11 Price is down by -6.6% in the last 24h. |
![]() |
GlucoTrack | August 10 Price is down by -6.3% in the last 24h. |
![]() |
GlucoTrack | August 7 Price is down by -6.3% in the last 24h. |
![]() |
GlucoTrack | August 6 Price is down by -8.6% in the last 24h. |
GlucoTrack Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 7K | N/A | |
| LinkedIn Employees | 1 | N/A | |
| Sentiment | 93 | N/A | |
| Reddit Mentions | 1 | N/A | |
| X Mentions | 1 | N/A | |
| Stocktwits Mentions | 343 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 5K | N/A |
About GlucoTrack (GCTK)
GlucoTrack, Inc., a medical device company, designs, develops and markets noninvasive glucose monitoring devices for people with diabetes and prediabetes in Europe and Asia Pacific. The company is headquartered in Or Yehuda, Israel.
| Price | $0.37 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $5M |
| Year Range | $0 – $1 |
| Dividend Yield | 0% |
| PE Ratio | 0.1 |
| Analyst Rating | 38% buy |
| Industry | Medical & Dental Instruments |
Latest GlucoTrack News
View more →
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for GlucotrackAugust 6 - GlobeNewswire |
GlucoTrack Earnings & Financial Performance
View all earnings →GlucoTrack Insider Trading Activity
View all →| BALLANTYNE JOHN filed to sell 59,260 shares at $0.0. Jul 30 '24 |
| BALLANTYNE JOHN filed to sell 76,191 shares at $0.0. Jul 30 '24 |
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 filed to sell 59,260 shares at $0.0. Jul 30 '24 |
| John A. Ballantyne Revocable Living Trust dated 08/01/2017 filed to sell 76,191 shares at $0.0. Jul 30 '24 |
| BALLANTYNE JOHN filed to sell 106,667 shares at $0.0. Jul 30 '24 |
GlucoTrack Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to GlucoTrack
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
![]() |
NexGelNXGL |
$0.43 17.6% | $4M | 40 |
![]() |
Innovative EyewearLUCY |
$0.70 0.2% | $6M | 52 |
![]() |
FemasysFEMY |
$2.35 0.8% | $7M | 47 |
![]() |
Retractable TechnologiesRVP |
$0.68 1.0% | $20M | 44 |
![]() |
Milestone ScientificMLSS |
$0.49 2.4% | $42M | 48 |
Explore GlucoTrack Data
Frequently Asked Questions: GlucoTrack (GCTK)
GlucoTrack has an AltIndex AI Score of 49/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
49/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of GlucoTrack (GCTK) stock is $0.37 with a market cap of $5M.
As of today, GlucoTrack’s PE (Price to Earnings) ratio is 0.1.
View the latest GlucoTrack insider transactions to see recent buying and selling activity by company executives and directors.
Check the GlucoTrack congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The GCTK stock price chart above shows GlucoTrack’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full GlucoTrack technical analysis for RSI, moving averages, and more.
See the stocks similar to GlucoTrack section on this page for companies in the same industry ranked by market cap and AI Score.




